SCCM Resource Library-MCS Review: From ECPR ECMO to Anticoagulation

Video Transcription

Video Summary

The video discusses anticoagulation strategies in extracorporeal life support and mechanical circulatory support devices. It covers topics such as the use of novel anticoagulants in mechanical circulatory support devices like left ventricular assist devices (LVADs), the use of bivalirudin as an alternative to heparin anticoagulation in ECMO and LVADs, the management of heparin-induced thrombocytopenia, and the early use of extracorporeal life support therapies in the emergency department. The first speaker discusses the management options for patients with heparin-induced thrombocytopenia. The second speaker talks about the use of novel oral anticoagulants, like bivalirudin, in mechanical circulatory devices. The third speaker focuses on the use of bivalirudin as an alternative to traditional heparin anticoagulation strategies. The fourth speaker discusses the early use of extracorporeal life support therapies in the emergency department. The session also covers the timing and selection criteria for ECMO in cardiac arrest patients, the use of ECMO in massive pulmonary embolism cases, and the importance of stakeholder buy-in and collaboration in implementing resuscitative ECMO programs. It concludes with a discussion on anticoagulation strategies during ECMO, emphasizing the need for further research on the optimal strategy. Overall, the video provides insights into anticoagulation strategies in mechanical circulatory support devices and the use of ECMO in resuscitative efforts, highlighting current practices and challenges in the field.

Asset Subtitle

Cardiovascular, Procedures, 2021

Asset Caption

The Society of Critical Care Medicine's Critical Care Congress features internationally renowned faculty and content sessions highlighting the most up-to-date, evidence-based developments in critical care medicine. This is a presentation from the 2021 Critical Care Congress held virtually from January 31-February 12, 2021.

Learning Objectives

Review clinical situations in which extracorporeal support protocols can be initiated in the emergency department
Identify anticoagulation options to manage advanced percutaneous mechanical circulatory support for patients with heparin-induced thrombocytopenia
Discuss new oral anticoagulation options for left ventricular assist devices
Compare a bivalirudin first approach over a heparin first approach for extracorporeal membrane oxygenation

HIT the Road Heparin: Impella Management With HIT
Zachary R. Smith

Leaving the Past Behind: Non-Warfarin Oral Anticoagulation for LVADs
Jessica Crow

B Before H: The Alphabet Never Lies About ECMO Anticoagulation
Eddy Fan

Clinical Utility of Early ECLS
Isaac Tawil

Meta Tag

Content Type Presentation

Knowledge Area Cardiovascular

Knowledge Area Procedures

Knowledge Level Advanced

Membership Level Select

Tag Ventricular Function

Tag Extracorporeal Membrane Oxygenation ECMO

Tag Cardiothoracic Critical Care

Year 2021

Keywords

anticoagulation strategies

extracorporeal life support

mechanical circulatory support devices

novel anticoagulants

LVADs

bivalirudin

heparin anticoagulation

ECMO

heparin-induced thrombocytopenia

emergency department

oral anticoagulants

cardiac arrest patients

pulmonary embolism cases

stakeholder buy-in

resuscitative ECMO programs

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.